Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Amarela Lukić-Grlić is active.

Publication


Featured researches published by Amarela Lukić-Grlić.


Journal of Clinical Microbiology | 2013

Full-Genome Characterization of a G8P[8] Rotavirus That Emerged among Children with Diarrhea in Croatia in 2006

Roberto Delogu; Alessandra Lo Presti; Franco Maria Ruggeri; Eleonora Cella; Marta Giovanetti; Massimo Ciccozzi; Sunčanica Ljubin-Sternak; Suzana Bukovski-Simonoski; Amarela Lukić-Grlić; Giovanni Ianiro; Lucia Fiore

ABSTRACT The whole genome of a G8P[8] rotavirus from the 2006 epidemic in Croatia was sequenced and showed a Wa-like genotype constellation. Its VP7 gene clustered with DS-1-like G8 African rotaviruses and a G8P[4] German strain. Remaining genes clustered with contemporary Belgian G1P[8] rotaviruses, suggesting reassortment between human G8 and G1P[8] rotaviruses in Croatia or other European countries.


Infection, Genetics and Evolution | 2016

Molecular characterization of class b carbapenemases in advanced stage of dissemination and emergence of class d carbapenemases in Enterobacteriaceae from Croatia.

Branka Bedenić; Sanda Sardelić; Josefa Luxner; Zrinka Bošnjak; Dijana Varda-Brkić; Amarela Lukić-Grlić; Ivana Mareković; Sonja Frančula-Zaninović; Marija Krilanović; Dorotea Šijak; Andrea J. Grisold; Gernot Zarfel

Carbapenemases involved in acquired carbapenem resistance in Enterobacteriaceae belong to Ambler class A serin β-lactamases, class B metallo-β-lactamases (MBL) or class D OXA-48-like β-lactamases. The aim of the present study was to analyse the molecular epidemiology and the mechanisms and routes of spread of class B and class D carbapenemases in Croatia. In total 68 isolates were analyzed. Antibiotic susceptibility was determined by broth microdilution method. PCR was used to detect antibiotic-resistance genes. Genotyping was performed by rep-PCR and MLST. Sixty-five isolates were found to harbour VIM-1 carbapenemase, seven of which were positive also for NDM-1, while two strains harboured only NDM-1. OXA-48 was detected in three isolates, two of which coproduced VIM-1. Thirty-six strains possessed additional CTX-M-15 β-lactamase whereas 64 were positive for TEM-1. CMY was found in 18 Citrobacter freundii isolates and DHA-1 in one Enterobacter cloacae isolate. Four different plasmid-incompatibility groups were found: A/C, L/M, N and FIIAs. Unlike C. freundii and E. cloacae, Klebsiella pneumoniae showed high diversity of rep-PCR patterns. E. cloacae and C. freundii predominantly belonged to one large clone which was allocated to ST105 and ST24, respectively. Three different types of carbapenemases were identified showing the complexity of CRE in Croatia.


Journal of Medical Microbiology | 2018

Epidemic spread of OXA-48 beta-lactamase in Croatia

Branka Bedenić; Mia Slade; Lidija Žele Starčević; Sanda Sardelić; Mirna Vranić-Ladavac; Ana Benčić; Vlasta Zujić Atalić; Maja Bogdan; Marina Bubonja-Šonje; Maja Tomić-Paradžik; Tatjana Tot; Amarela Lukić-Grlić; Domagoj Drenjančević; Dijana Varda-Brkić; Daniela Bandić-Pavlović; Slobodan Mihaljević; Gernot Zarfel; Marija Gužvinec; Rick Conzemius; Ivan Barišić; Arjana Tambić-Andraševic

Purpose. A dramatic increase in OXA‐48 &bgr;‐lactamase was observed recently not only in large hospital centres, but also in smaller suburban hospital centres in geographic areas bordering Croatia. The aim of the study was to analyse the epidemiology, the mechanisms of antibiotic resistance and the routes of spread of OXA‐48 carbapenemase in Croatia. Methods. Carbapenemase and other &bgr;‐lactamase and fluoroquinolone resistance genes were detected by PCR and sequencing. Whole‐genome sequencing (WGS) was performed on five representative isolates. The isolates were genotyped by PFGE. Results. Forty‐eight isolates positive for OXA‐48, collected from seven hospital centres in Croatia from May 2016 to May 2017, were analysed (40 Klebsiella pneumoniae, 5 Enterobacter cloacae, 2 Escherichia coli and one Citrobacter freundii). Thirty‐three isolates were ESBL positive and harboured group 1 CTX‐M 1 &bgr;‐lactamases. In addition to the &bgr;‐lactam resistance genes detected by PCR (blaSHV‐1, blaOXA‐48 and blaOXA‐1), WGS of five representative isolates revealed the presence of genes encoding aminoglycoside resistance, aadA2 and aph3‐Ia, fluoroquinolone resistance determinants aac(6)Ib‐c, oqxA and oqxB, the sulfonamide resistance gene sul1, and fosA (fosfomycin resistance). IncL plasmid was found in all isolates. Two K. pneumoniae isolates belonged to ST16, two E. cloacae to ST66 and E. coli to ST354. K. pneumoniae isolates were allocated to five clusters by PFGE which occured in different hospitals, indicating epidemic spread. Conclusions. The OXA‐48‐positive organisms found in this study showed wide variability in antibiotic susceptibility, &bgr;‐lactamase content and PFGE banding patterns. This study revealed a switch from the predominance of VIM‐1 in 2012–2013 to that of OXA‐48 in the 2015 to 2017.


CEN Case Reports | 2018

NDM-1-producing Enterobacter aerogenes isolated from a patient with a JJ ureteric stent in situ

Irena Franolić; Branka Bedenić; Nataša Beader; Amarela Lukić-Grlić; Slobodan Mihaljević; Luka Bielen; Gernot Zarfel; Tomislav Meštrović

Urinary tract infections after JJ stent insertion are among the most common complications, and the associated microorganisms carry more antibiotic resistance determinants than those found in urine prior to stent insertion. In line with the trends in healthcare epidemiology which implicate multi-resistant microorganisms in a plethora of healthcare-associated infections, prosthetic stent material also represents an ideal milieu for biofilm formation and subsequent infection development with resistant bacterial agents. Here we describe a case of a 73-year-old Caucasian woman presenting with urinary tract infection after JJ ureteric stent insertion due to ureteric obstruction and hydronephrosis of her left kidney. Extensive microbiological work-up and comprehensive molecular analysis identified the putative microorganism as carbapenem-resistant Enterobacter aerogenes carrying New Delhi metallo-beta-lactamase 1 (NDM-1). This is a first literature report implicating such extensively resistant strain of this species in early indwelling ureteric stent complications, and also the first report of NDM-1 in Enterobacter aerogenes in Croatia and Europe.


Journal of Medical Microbiology | 2011

Candida utilis candidaemia in neonatal patients

Amarela Lukić-Grlić; Emilija Mlinaric-Missoni; Ivančica Škarić; Verica Vazic-Babic; Ivan-Krešimir Svetec


Acta Virologica | 2007

Norovirus genotypes involved in the outbreaks of gastroenteritis in Croatia during the winter season 2004--2005.

Sunčanica Ljubin-Sternak; Amarela Lukić-Grlić; Lucia Fiore; I. di Bartolo; Franco Maria Ruggeri; Suzana Bukovski-Simonoski; Gordana Mlinarić-Galinović


Collegium Antropologicum | 2012

Lower Urinary Tract Infections and the Effects of Hormone Therapy in Postmenopausal Women in the Zagreb Region

Blaženka Hunjak; Štefica Findri-Guštek; Branko Kolarić; Ivan Fistonić; Amarela Lukić-Grlić; Gordana Vojnović


Journal of Infection and Chemotherapy | 2018

In vitro synergy and postantibiotic effect of colistin combinations with meropenem and vancomycin against Enterobacteriaceae with multiple carbapenem resistance mechanisms

Branka Bedenić; Haris Car; Domagoj Slačanac; Mario Sviben; Marko Čačić; Amarela Lukić-Grlić; Ana Benčić; Dorotea Šijak; Marko Tripković; Nataša Beader


Eccmid2017, abstracts online library | 2018

In vitro synergy and postantibiotic effect of colistin combined with meropenem against Enterobacteriaceae with multiple carbapenem resistance mechanisms

Branka Bedenić; Nataša Beader; Sonja Frančula Zaninović; Dijana Varda-Brkić; Vesna Tripković; Dorotea Šija; Marko Čačić; Ana Benčić; Amarela Lukić-Grlić; Ivan Barišić; Domagoj Slačanac; Mirna Vranić-Ladavac; Sanda Sardelić; Mario Sviben


Lijec̆nic̆ki vjesnik | 2016

EVOLUTION OF BETA-LACTAM ANTIBIOTIC RESISTANCE IN ENTEROBACTER SPP. IN CROATIA

Irena Franolić-Kukina; Sanda Sardelić; Nataša Beader; Dijana Varda-Brkić; Nataša Firis; Marko Čačić; Dorotea Šijak; Sonja Frančula-Zaninović; Vesna Elveđi-Gašparović; Ivana Mareković; Amarela Lukić-Grlić; Mihaela Ajman; Branka Bedenić

Collaboration


Dive into the Amarela Lukić-Grlić's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gernot Zarfel

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge